Harrow (HROW) Other Non Operating Income (2010 - 2025)
Harrow's (HROW) quarterly Other Non Operating Income came in at $7.8 million in Q4 2025, up 3087.36% year-on-year from $244622.8 in Q4 2024, and up 200.61% quarter-over-quarter from -$7.8 million in Q3 2025.
Harrow (HROW) Other Non Operating Income (2010 - 2025) Analysis & Trends
Harrow's Other Non Operating Income history runs 11 years deep, the most recent figure standing at $7.8 million for Q4 2025.
- On a quarterly basis, Other Non Operating Income rose 3087.36% year-over-year to $7.8 million in Q4 2025; TTM through Dec 2025 was -$220000.0, a 18.92% decrease from a year earlier, with the FY2025 full-year figure at $47000.0, up 125.41% from the prior year.
- Other Non Operating Income climbed to $7.8 million in Q4 2025 per HROW's latest filing, from -$7.8 million in the prior quarter.
- Across five years, Other Non Operating Income topped out at $7.8 million in Q4 2025 and bottomed at -$7.8 million in Q3 2025.
- The 4-year median for Other Non Operating Income is -$100000.0 (2023), against an average of -$526000.0.
- Biggest YoY gain for Other Non Operating Income was 3087.36% in 2025; the steepest drop was 193850.0% in 2025.
- Year by year, Other Non Operating Income stood at -$705000.0 in 2021, then jumped by 85.82% to -$100000.0 in 2023, then plunged by 161.0% to -$261000.0 in 2024, then soared by 3087.36% to $7.8 million in 2025.
- Per Business Quant, the three latest HROW Other Non Operating Income figures stand at $7.8 million (Q4 2025), -$7.8 million (Q3 2025), and -$6000.0 (Q2 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Harrow | 1.56 Bn | 1.47 Bn | 27.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 7.80 Mn |
| Sep 30, 2025 | -7.75 Mn |
| Jun 30, 2025 | -6,000.00 |
| Dec 31, 2024 | -261,000.00 |
| Sep 30, 2024 | 4,000.00 |
| Jun 30, 2024 | 46,000.00 |
| Mar 31, 2024 | 26,000.00 |
| Dec 31, 2023 | -100,000.00 |
| Sep 30, 2023 | -195,000.00 |
| Jun 30, 2023 | -178,000.00 |
| Mar 31, 2023 | -5.47 Mn |
| Dec 31, 2021 | -705,000.00 |
| Jun 30, 2021 | -51,000.00 |
| Dec 31, 2020 | -97,000.00 |
| Sep 30, 2020 | 5,000.00 |
| Jun 30, 2020 | 19,000.00 |
| Mar 31, 2019 | 630,000.00 |
| Dec 31, 2018 | 358,000.00 |
| Jun 30, 2018 | -255,000.00 |
| Dec 31, 2017 | -6.61 Mn |